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non-proliferating (Q) cells, which may differ
in their sensitivity to drugs or ionizing
radiation. Experimental data on changes in
cell proliferation characteristics of a trans-
plantable R-1 rat rhabdomyosarcoma have
shown that the fraction of P cells may
increase and the cell cycle time may decrease
after irradiation. This has led to experiments
on the effectiveness of a cell cycle-specific
drug given at various time jntervals after
irradiation.
Growth delay of the R-1 rhabdomyo-
sarcoma was measured after doses of2000 rad
or 1000 rad of x-rays, followed at intervals of
up to 12 days by the administration of
vinblastine at a dose level of 1-5 mg/kg of
body weight. This dose of vinblastine alone
induced a growth delay of 2.5 days, while
1000 rad and 2000 rad of x-rays induced
growth delays of 7 and 15 days respectively.
Vinblastine given 8 h before irradiation gave
approximately the same effect as irradiation
only, but vinblastine given 48-192 h after
irradiation caused a very significant excess
delayofabout 8 days over that expected from
a directly additive action. This can be
ascribed to recruitment of Q cells into the
compartment ofP cells. Asimilarsynergistic
effect was observed for a rat osteosarcoma but
not for a rat skin carcinoma and a rat bladder
carcinoma.
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An external assay has been developed and
modified in this laboratory that permits the
evaluation of the effects of radiation and/or
drugs in the living mouse. Cells are labelled
in vivo with iododeoxyuridine (1251UdR).
IUdR is an analogue of thymidine; both
precursors are specifically and rapidly incor-
porated into DNA of S cells at the time the
precursors are made available. Reutilization
of IUdR is minimal; therefore labelled
IUdR is the tracer of choice for turnover
studies. The soft y-rays from 1251 are easily
measured externally, either with the whole
body counter or with a tumour measuring
device specifically developed for assaying
solid tumours.
This paper reports on the effect of radia-
tion and/or drugs on the rate ofincorporation
of '25JUdR into whole body DNA and
tumour DNA in the living mouse. In
addition, the effect of actinomycin D on the
rate ofturnover oflabelled tumour cells in the
living mouse was assayed. Prolonged obser-
vations in the living organism with this
technique do not disturb the physiological
equilibrium, be it in normal or in tumour
bearing animals. In this study, sarcoma-180
was used as a solitary tumour growing in the
hind leg ofNMRI mice; 10-12 mice were used
per experimental point.
The incorporation of 125IUdR into whole
body DNA on one hand and tumour DNA on
the other hand was measured in the living
mice at various times after acute exposure to
y-radiation, neutron radiation or after a
single administration offluorouracil, hydroxy-
urea and actinomycin D. Each of these
treatments caused a specific effect ofdifferent
duration and the maximum effect in the
whole body surpassed that observed for the
tumour. On the other hand, a single
administration of a platinum complex
compound (cis-dichloro-diammine-platinum)
caused not only prolonged effects in the whole
body and tumour but the effects to the
tumour surpassed that of the whole body:
combined effects of actinomycin D and
radiotherapy on sarcoma-180 were different
from those seen in the whole body. In both
instances, the additional effect ofactinomycin
D resembled the maximal effect of either
treatment alone. It was found that actino-
mycin D enhanced the radiation effect on
tumour growth when it was given 3-4 h
either before or after irradiation. Actino-
mycin D treatment or combined therapy
indicated that actinomycin D alone had little
effect on cell loss rate from labelled tumours.
Combined therapy did not significantly alter
the increased rate of cell loss observed for
radiotherapy alone, yet combined therapy
appeared to cause the enhanced cell loss rate
to be prolonged in comparison with radio-
therapy alone.
COMBINED EFFECT OF 5-FU AND
60Co ON INTESTINE, BONE
MARROW AND ON TRANSPLANTED
TUMOUR IN MICE. A POSSIBLE